Maintenance of Investigator's Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis

• Главные авторы: Lawrence F. Eichenfield (Автор), Linda F. Stein Gold (Автор), Charles Lynde (Автор), Lyn Guenther (Автор), Shoshana Greenberger (Автор), Chia-Yu Chu (Автор), Zara Ghodsi (Автор), Bonnie Vlahos (Автор), Paul Sanders (Автор), Amy Cha (Автор), Juliana M. Canosa (Автор)
• Формат: ‌
• Опубликовано: Adis, Springer Healthcare, 2024-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Introduction Treatments for atopic dermatitis (AD) often fail to achieve lasting disease control. In the CrisADe CONTROL phase III study (ClinicalTrials.gov: NCT04040192), participants aged ≥ 3 months with mild to moderate AD treated with once-daily (QD) crisaborole, following initial treat...